Splits – PharmaLive

Lilly Bio-Medicines splitting into two business units

Appointments, Business, Eli Lilly, Immunology, Neuroscience, People on the Move, Splits

Eli Lilly is undertaking a strategic transformation that will result in the formation of new business units. The Indianapolis company’s Bio-Medicines unit will split into two separate businesses, with one focused on neuroscience and the other concentrated on immunology.

August 17, 2021/by BioSpace

Activist Investor Continues Campaign Against Walmsley, GSK Leadership

Activists, Business, Demergers, GlaxoSmithKline, Investors, Splits

Activist investor Elliott Management continues to push for a change in leadership at GlaxoSmithKline ahead of the planned 2022 split of the company.

July 1, 2021/by Andrew Humphreys

GSK Chairman Steps Down Ahead of Company Split

Business, Consumer Healthcare, Equity Stake, PARP Inhibitors, People on the Move, Pharma, Product Pipeline, Shares, Splits

GlaxoSmithKline Chairman Sir Philip Hampton will step down from his role ahead of the company’s plan to split into two separate business units.

January 21, 2019/by BioSpace

Pfizer abandons plan to split into two companies

Analysts, Business, Cash Flow, Forecasts, Health, Investors, M&A, Shareholder Value, Splits

Pfizer, which was considering a split into two companies for more than two years, said it would not do so because the move would not create any shareholder value.

September 26, 2016/by Reuters Health

Stock Pops as Medivir Decides to Split into Two Companies

Biotech, Business, Cathepsin K Inhibitors, Clinical Trials, HCV nucleotide analogue NS5B polymerase inhibitors, Health, Hepatitis C, Hepatocellular Carcinoma, HIV, Nasdaq First North, R&D, Respiratory Syncytial Virus, Splits, Stocks

Medivir AB announced that it plans to split up into two independent companies.

August 31, 2016/by BioSpace